Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 408 entries
Sorted by: Best Match Show Resources per page
Ginger: A complementary approach for management of cardiovascular diseases.

BioFactors (Oxford, England)

Roudsari NM, Lashgari NA, Momtaz S, Roufogalis B, Abdolghaffari AH, Sahebkar A.
PMID: 34388275
Biofactors. 2021 Nov;47(6):933-951. doi: 10.1002/biof.1777. Epub 2021 Aug 13.

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide. Inflammation and oxidative stress play critical roles in progression of various types of CVD. Broad pharmacological properties of ginger (the rhizome of Zingiber officinale) and its bioactive...

Cite
Roudsari NM, Lashgari NA, Momtaz S, et al. Ginger: A complementary approach for management of cardiovascular diseases. Biofactors. 2021;47(6):933-951doi: 10.1002/biof.1777.
Roudsari, N. M., Lashgari, N. A., Momtaz, S., Roufogalis, B., Abdolghaffari, A. H., & Sahebkar, A. (2021). Ginger: A complementary approach for management of cardiovascular diseases. BioFactors (Oxford, England), 47(6), 933-951. https://doi.org/10.1002/biof.1777
Roudsari, Nazanin Momeni, et al. "Ginger: A complementary approach for management of cardiovascular diseases." BioFactors (Oxford, England) vol. 47,6 (2021): 933-951. doi: https://doi.org/10.1002/biof.1777
Roudsari NM, Lashgari NA, Momtaz S, Roufogalis B, Abdolghaffari AH, Sahebkar A. Ginger: A complementary approach for management of cardiovascular diseases. Biofactors. 2021 Nov;47(6):933-951. doi: 10.1002/biof.1777. Epub 2021 Aug 13. PMID: 34388275.
Copy Download .nbib Format: NLM
Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence.

Journal of diabetes research

Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A.
PMID: 34660812
J Diabetes Res. 2021 Oct 07;2021:7796727. doi: 10.1155/2021/7796727. eCollection 2021.

The modern lifestyle has a negative impact on health. It is usually accompanied by increased stress levels and lower physical activity, which interferes with body homeostasis. Diabetes mellitus is a relatively common metabolic disorder with increasing prevalence globally, associated...

Cite
Yaribeygi H, Maleki M, Sathyapalan T, et al. Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence. J Diabetes Res. 2021;2021:7796727doi: 10.1155/2021/7796727.
Yaribeygi, H., Maleki, M., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021). Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence. Journal of diabetes research, 20217796727. https://doi.org/10.1155/2021/7796727
Yaribeygi, Habib, et al. "Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence." Journal of diabetes research vol. 2021 (2021): 7796727. doi: https://doi.org/10.1155/2021/7796727
Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A. Pathophysiology of Physical Inactivity-Dependent Insulin Resistance: A Theoretical Mechanistic Review Emphasizing Clinical Evidence. J Diabetes Res. 2021 Oct 07;2021:7796727. doi: 10.1155/2021/7796727. eCollection 2021. PMID: 34660812; PMCID: PMC8516544.
Copy Download .nbib Format: NLM
Therapeutic Effects of .

Journal of nutrition and metabolism

Eghbali S, Askari SF, Avan R, Sahebkar A.
PMID: 34796029
J Nutr Metab. 2021 Nov 16;2021:5297162. doi: 10.1155/2021/5297162. eCollection 2021.

No abstract available.

Cite
Eghbali S, Askari SF, Avan R, et al. Therapeutic Effects of . J Nutr Metab. 2021;2021:5297162doi: 10.1155/2021/5297162.
Eghbali, S., Askari, S. F., Avan, R., & Sahebkar, A. (2021). Therapeutic Effects of . Journal of nutrition and metabolism, 20215297162. https://doi.org/10.1155/2021/5297162
Eghbali, Samira, et al. "Therapeutic Effects of ." Journal of nutrition and metabolism vol. 2021 (2021): 5297162. doi: https://doi.org/10.1155/2021/5297162
Eghbali S, Askari SF, Avan R, Sahebkar A. Therapeutic Effects of . J Nutr Metab. 2021 Nov 16;2021:5297162. doi: 10.1155/2021/5297162. eCollection 2021. PMID: 34796029; PMCID: PMC8595036.
Copy Download .nbib Format: NLM
Phosphatidylserine-containing liposomes: Therapeutic potentials against hypercholesterolemia and atherosclerosis.

European journal of pharmacology

Naeini MB, Momtazi-Borojeni AA, Ganjali S, Kontush A, Jaafari MR, Sahebkar A.
PMID: 34245747
Eur J Pharmacol. 2021 Oct 05;908:174308. doi: 10.1016/j.ejphar.2021.174308. Epub 2021 Jul 07.

Liposomes have been suggested as potential tools for cholesterol deposit mobilization from atherosclerotic lesions. Here, we explored the anti-atherosclerotic effects of phosphatidylserine (PS)-containing liposomes in vivo. High-fat diet-fed New Zealand white rabbits which were divided into groups receiving weekly...

Cite
Naeini MB, Momtazi-Borojeni AA, Ganjali S, et al. Phosphatidylserine-containing liposomes: Therapeutic potentials against hypercholesterolemia and atherosclerosis. Eur J Pharmacol. 2021;908:174308doi: 10.1016/j.ejphar.2021.174308.
Naeini, M. B., Momtazi-Borojeni, A. A., Ganjali, S., Kontush, A., Jaafari, M. R., & Sahebkar, A. (2021). Phosphatidylserine-containing liposomes: Therapeutic potentials against hypercholesterolemia and atherosclerosis. European journal of pharmacology, 908174308. https://doi.org/10.1016/j.ejphar.2021.174308
Naeini, Mehri Bemani, et al. "Phosphatidylserine-containing liposomes: Therapeutic potentials against hypercholesterolemia and atherosclerosis." European journal of pharmacology vol. 908 (2021): 174308. doi: https://doi.org/10.1016/j.ejphar.2021.174308
Naeini MB, Momtazi-Borojeni AA, Ganjali S, Kontush A, Jaafari MR, Sahebkar A. Phosphatidylserine-containing liposomes: Therapeutic potentials against hypercholesterolemia and atherosclerosis. Eur J Pharmacol. 2021 Oct 05;908:174308. doi: 10.1016/j.ejphar.2021.174308. Epub 2021 Jul 07. PMID: 34245747.
Copy Download .nbib Format: NLM
Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates.

Molecular biology reports

Namaki M, Habibzadeh S, Vaez H, Arzanlou M, Safarirad S, Bazghandi SA, Sahebkar A, Khademi F.
PMID: 34854015
Mol Biol Rep. 2021 Dec 01; doi: 10.1007/s11033-021-07032-2. Epub 2021 Dec 01.

BACKGROUND: Biocides are frequently used as preservative, disinfectant and sterilizer against many microorganisms in hospitals, industry and home. However, the reduced susceptibility rate of Pseudomonas aeruginosa (P. aeruginosa) strains to biocides is increasing. The aim of this study was...

Cite
Namaki M, Habibzadeh S, Vaez H, et al. Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates. Mol Biol Rep. 2021;doi: 10.1007/s11033-021-07032-2.
Namaki, M., Habibzadeh, S., Vaez, H., Arzanlou, M., Safarirad, S., Bazghandi, S. A., Sahebkar, A., & Khademi, F. (2021). Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates. Molecular biology reports, . https://doi.org/10.1007/s11033-021-07032-2
Namaki, Malek, et al. "Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates." Molecular biology reports vol. (2021). doi: https://doi.org/10.1007/s11033-021-07032-2
Namaki M, Habibzadeh S, Vaez H, Arzanlou M, Safarirad S, Bazghandi SA, Sahebkar A, Khademi F. Prevalence of resistance genes to biocides in antibiotic-resistant Pseudomonas aeruginosa clinical isolates. Mol Biol Rep. 2021 Dec 01; doi: 10.1007/s11033-021-07032-2. Epub 2021 Dec 01. PMID: 34854015.
Copy Download .nbib Format: NLM
Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage.

Current molecular pharmacology

Gorabi AM, Kiaie N, Bianconi V, Pirro M, Jamialahmadi T, Sahebkar A.
PMID: 33568040
Curr Mol Pharmacol. 2021;14(5):782-797. doi: 10.2174/1874467214666210210123206.

Cardiac fibrosis is a maladaptive condition secondary to cardiomyopathy caused by a wide spectrum of stimuli, including myocardial infarction (MI), pressure overload, hyperglycemia, aging, and other factors. Despite having been supposed to be a reparative mechanism, the development of...

Cite
Gorabi AM, Kiaie N, Bianconi V, et al. Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage. Curr Mol Pharmacol. 2021;14(5):782-797doi: 10.2174/1874467214666210210123206.
Gorabi, A. M., Kiaie, N., Bianconi, V., Pirro, M., Jamialahmadi, T., & Sahebkar, A. (2021). Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage. Current molecular pharmacology, 14(5), 782-797. https://doi.org/10.2174/1874467214666210210123206
Gorabi, Armita M, et al. "Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage." Current molecular pharmacology vol. 14,5 (2021): 782-797. doi: https://doi.org/10.2174/1874467214666210210123206
Gorabi AM, Kiaie N, Bianconi V, Pirro M, Jamialahmadi T, Sahebkar A. Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage. Curr Mol Pharmacol. 2021;14(5):782-797. doi: 10.2174/1874467214666210210123206. PMID: 33568040.
Copy Download .nbib Format: NLM
Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence.

BioMed research international

Bahrami A, Montecucco F, Carbone F, Sahebkar A.
PMID: 34692844
Biomed Res Int. 2021 Oct 13;2021:8972074. doi: 10.1155/2021/8972074. eCollection 2021.

Aging is characterized by a progressive inability to maintain homeostasis, self-repair, renewal, performance, and fitness of different tissues throughout the lifespan. Senescence is occurring following enormous intracellular or extracellular stress stimuli. Cellular senescence serves as an antiproliferative process that...

Cite
Bahrami A, Montecucco F, Carbone F, et al. Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence. Biomed Res Int. 2021;2021:8972074doi: 10.1155/2021/8972074.
Bahrami, A., Montecucco, F., Carbone, F., & Sahebkar, A. (2021). Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence. BioMed research international, 20218972074. https://doi.org/10.1155/2021/8972074
Bahrami, Afsane, et al. "Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence." BioMed research international vol. 2021 (2021): 8972074. doi: https://doi.org/10.1155/2021/8972074
Bahrami A, Montecucco F, Carbone F, Sahebkar A. Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence. Biomed Res Int. 2021 Oct 13;2021:8972074. doi: 10.1155/2021/8972074. eCollection 2021. PMID: 34692844; PMCID: PMC8528582.
Copy Download .nbib Format: NLM
Antiviral Plants in View of Avicenna's The Canon of Medicine and Modern Medicine Against Common Cold.

Advances in experimental medicine and biology

Ramazani E, Emami SA, Tayarani-Najaran N, Sahebkar A, Tayarani-Najaran Z.
PMID: 34981473
Adv Exp Med Biol. 2021;1328:99-121. doi: 10.1007/978-3-030-73234-9_7.

Common cold is known as a serious clinical problem worldwide. Coronaviruses have long been identified as respiratory pathogens causing "common cold" in healthy people. The pandemic of 2019 novel coronavirus as a serious public health problem and concern has...

Cite
Ramazani E, Emami SA, Tayarani-Najaran N, et al. Antiviral Plants in View of Avicenna's The Canon of Medicine and Modern Medicine Against Common Cold. Adv Exp Med Biol. 2021;1328:99-121doi: 10.1007/978-3-030-73234-9_7.
Ramazani, E., Emami, S. A., Tayarani-Najaran, N., Sahebkar, A., & Tayarani-Najaran, Z. (2021). Antiviral Plants in View of Avicenna's The Canon of Medicine and Modern Medicine Against Common Cold. Advances in experimental medicine and biology, 132899-121. https://doi.org/10.1007/978-3-030-73234-9_7
Ramazani, Elham, et al. "Antiviral Plants in View of Avicenna's The Canon of Medicine and Modern Medicine Against Common Cold." Advances in experimental medicine and biology vol. 1328 (2021): 99-121. doi: https://doi.org/10.1007/978-3-030-73234-9_7
Ramazani E, Emami SA, Tayarani-Najaran N, Sahebkar A, Tayarani-Najaran Z. Antiviral Plants in View of Avicenna's The Canon of Medicine and Modern Medicine Against Common Cold. Adv Exp Med Biol. 2021;1328:99-121. doi: 10.1007/978-3-030-73234-9_7. PMID: 34981473.
Copy Download .nbib Format: NLM
The efficacy of herbal medicine in the treatment of recurrent aphthous stomatitis: A systematic review of randomized clinical trials.

Phytotherapy research : PTR

Shavakhi M, Sahebkar A, Shirban F, Bagherniya M.
PMID: 34816511
Phytother Res. 2021 Nov 23; doi: 10.1002/ptr.7332. Epub 2021 Nov 23.

This systematic review was undertaken with the main aim of assessing the therapeutic effects of herbal medicines in recurrent aphthous stomatitis (RAS). A comprehensive search was performed in PubMed, Scopus, ISI Web of Science, and Google Scholar up to...

Cite
Shavakhi M, Sahebkar A, Shirban F, et al. The efficacy of herbal medicine in the treatment of recurrent aphthous stomatitis: A systematic review of randomized clinical trials. Phytother Res. 2021;doi: 10.1002/ptr.7332.
Shavakhi, M., Sahebkar, A., Shirban, F., & Bagherniya, M. (2021). The efficacy of herbal medicine in the treatment of recurrent aphthous stomatitis: A systematic review of randomized clinical trials. Phytotherapy research : PTR, . https://doi.org/10.1002/ptr.7332
Shavakhi, Mojgan, et al. "The efficacy of herbal medicine in the treatment of recurrent aphthous stomatitis: A systematic review of randomized clinical trials." Phytotherapy research : PTR vol. (2021). doi: https://doi.org/10.1002/ptr.7332
Shavakhi M, Sahebkar A, Shirban F, Bagherniya M. The efficacy of herbal medicine in the treatment of recurrent aphthous stomatitis: A systematic review of randomized clinical trials. Phytother Res. 2021 Nov 23; doi: 10.1002/ptr.7332. Epub 2021 Nov 23. PMID: 34816511.
Copy Download .nbib Format: NLM
Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies.

Advances in pharmacological and pharmaceutical sciences

Stamerra CA, Del Pinto R, di Giosia P, Ferri C, Sahebkar A.
PMID: 34095851
Adv Pharmacol Pharm Sci. 2021 May 13;2021:5548445. doi: 10.1155/2021/5548445. eCollection 2021.

The Anderson-Fabry disease is a rare, X-linked, multisystemic, progressive lysosomal storage disease caused by

Cite
Stamerra CA, Del Pinto R, di Giosia P, et al. Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies. Adv Pharmacol Pharm Sci. 2021;2021:5548445doi: 10.1155/2021/5548445.
Stamerra, C. A., Del Pinto, R., di Giosia, P., Ferri, C., & Sahebkar, A. (2021). Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies. Advances in pharmacological and pharmaceutical sciences, 20215548445. https://doi.org/10.1155/2021/5548445
Stamerra, Cosimo A, et al. "Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies." Advances in pharmacological and pharmaceutical sciences vol. 2021 (2021): 5548445. doi: https://doi.org/10.1155/2021/5548445
Stamerra CA, Del Pinto R, di Giosia P, Ferri C, Sahebkar A. Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies. Adv Pharmacol Pharm Sci. 2021 May 13;2021:5548445. doi: 10.1155/2021/5548445. eCollection 2021. PMID: 34095851; PMCID: PMC8137293.
Copy Download .nbib Format: NLM
A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures.

Cannabis and cannabinoid research

Brodie MJ, Czapinski P, Pazdera L, Sander JW, Toledo M, Napoles M, Sahebkar F, Schreiber A.
PMID: 33998885
Cannabis Cannabinoid Res. 2021 Dec;6(6):528-536. doi: 10.1089/can.2020.0075. Epub 2021 Feb 15.

No abstract available.

Cite
Brodie MJ, Czapinski P, Pazdera L, et al. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res. 2021;6(6):528-536doi: 10.1089/can.2020.0075.
Brodie, M. J., Czapinski, P., Pazdera, L., Sander, J. W., Toledo, M., Napoles, M., Sahebkar, F., Schreiber, A. (2021). A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis and cannabinoid research, 6(6), 528-536. https://doi.org/10.1089/can.2020.0075
Brodie, Martin J, et al. "A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures." Cannabis and cannabinoid research vol. 6,6 (2021): 528-536. doi: https://doi.org/10.1089/can.2020.0075
Brodie MJ, Czapinski P, Pazdera L, Sander JW, Toledo M, Napoles M, Sahebkar F, Schreiber A. A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures. Cannabis Cannabinoid Res. 2021 Dec;6(6):528-536. doi: 10.1089/can.2020.0075. Epub 2021 Feb 15. PMID: 33998885; PMCID: PMC8713263.
Copy Download .nbib Format: NLM
Comparative effects of on-pump versus off-pump coronary artery bypass grafting surgery on serum cytokine and chemokine levels.

IUBMB life

Mirhafez SR, Khadem SH, Sahebkar A, Movahedi A, Rahsepar AA, Mirzaie A, Jamialahmadi T, Ferns GA, Ghayour-Mobarhan M.
PMID: 34601812
IUBMB Life. 2021 Dec;73(12):1423-1431. doi: 10.1002/iub.2566. Epub 2021 Oct 15.

Coronary artery bypass grafting (CABG) surgery with two methods (on-pump or off-pump) can be used to rescue individuals with severe coronary artery disease (CAD). Each method might cause an inflammatory response, which can lead to some complications. The aim...

Cite
Mirhafez SR, Khadem SH, Sahebkar A, et al. Comparative effects of on-pump versus off-pump coronary artery bypass grafting surgery on serum cytokine and chemokine levels. IUBMB Life. 2021;73(12):1423-1431doi: 10.1002/iub.2566.
Mirhafez, S. R., Khadem, S. H., Sahebkar, A., Movahedi, A., Rahsepar, A. A., Mirzaie, A., Jamialahmadi, T., Ferns, G. A., & Ghayour-Mobarhan, M. (2021). Comparative effects of on-pump versus off-pump coronary artery bypass grafting surgery on serum cytokine and chemokine levels. IUBMB life, 73(12), 1423-1431. https://doi.org/10.1002/iub.2566
Mirhafez, Seyed Reza, et al. "Comparative effects of on-pump versus off-pump coronary artery bypass grafting surgery on serum cytokine and chemokine levels." IUBMB life vol. 73,12 (2021): 1423-1431. doi: https://doi.org/10.1002/iub.2566
Mirhafez SR, Khadem SH, Sahebkar A, Movahedi A, Rahsepar AA, Mirzaie A, Jamialahmadi T, Ferns GA, Ghayour-Mobarhan M. Comparative effects of on-pump versus off-pump coronary artery bypass grafting surgery on serum cytokine and chemokine levels. IUBMB Life. 2021 Dec;73(12):1423-1431. doi: 10.1002/iub.2566. Epub 2021 Oct 15. PMID: 34601812.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 408 entries